Skip Navigation OSO HomeOffice of Scientific Opportunities
Working Groups
Cancer GeneticsModelsImagingSignatures

NCI Home


What is an Extraordinary Opportunity?
Advisory Committee to the Director

Feedback
Staff
OSO Home
Members

CO-CHAIRS

Douglas Hanahan, Ph.D.
Professor
Department of Biochemistry and Biophysics
University of California, San Francisco

H. Robert Horvitz, Ph.D.
Professor of Biology
Massachusetts Institute of Technology

EXECUTIVE SECRETARY

Susan Waldrop
Assistant Director for Program Coordination
National Cancer Institute
E-mail: sw40j@nih.gov

 
   
MEMBERS
Carmen Allegra, M.D. Arnold Levine, Ph.D.
David Baltimore, Ph.D. Ronald Lubet, Ph.D.
Mina Bissell, Ph.D. Lynn M. Matrisian, Ph.D.
Neal Copeland, Ph.D. John Minna, M.D.
William Dove, Ph.D. Allen Oliff, M.D.
Judah Folkman, M.D. Kenneth Paigen, Ph.D.
Jackson Gibbs, Ph.D. Gerald M. Rubin, Ph.D.
Edward Harlow, Ph.D. Edward A. Sausville, M.D., Ph.D.
Ira Herskowitz, Ph.D. John Sogn, Ph.D.
Peter Howley, M. D. Judy Vaitukaitis, M.D.
Tyler Jacks, Ph.D. George Vande Woude, Ph.D.
Marc Kirschner, Ph.D. Harold Varmus, M.D.
Richard Klausner, M.D. Susan Waldrop
Stanley Korsmeyer, M.D. Robert Wittes, M.D.
Eric Lander, Ph.D.

Members
Activites in Brief
What's New
Initiatives

 

Extraordinary Opportunities.....Cancer Genetics.....Preclinical Models.....Imaging.....Signatures
Advisory Committee to the Director.....Director's Working Groups.....Office of Science Policy
Feedback.....Home